Has GW Pharmaceuticals – Now Jazz Pharmaceuticals – Knee-Capped The CBD Industry?
WITH the fast-growing CBD sector tied up in a regulatory quagmire hundreds of transatlantic industry players face an uncertain future. However, one UK company – the one which pioneered the medical use of the cannabis extract cannabidiol – will have an all together different take on events. GW Pharmaceuticals,... Read more
Maryland’s New Cannabis Regulations Are Problematic for Stakeholders, Investors
There are murmurs of serious discontent regarding Maryland’s proposed cannabis regulations – HB0556/SB0516 – which had their first readings earlier this month, kicking off a legislative process that has a long way to go and contains myriad opportunities for the bills to be amended to address the concerns of... Read more
Indiana lawmakers hear, but don’t vote on, bill decriminalizing marijuana
A bill decriminalizing the possession of two ounces, or less, of marijuana received a hearing before a House committee Wednesday but isn’t expected to get additional consideration. Rep. Wendy McNamara, R-Evansville, chairs the House courts committee and said the dialogue needed to be heard but didn’t call a vote on the... Read more
Medical marijuana debate resumes in North Carolina Senate
Debate on the legalization of marijuana in North Carolina for medical purposes returned on Wednesday to the state Senate, where a very similar measure creating the framework for its sale and use passed the full chamber by a wide margin just eight months ago. The Senate Judiciary Committee debated... Read more
Pa. Department of Health sues to keep medical marijuana program data secret
The Pennsylvania Department of Health is again suing Spotlight PA in an attempt to keep information about how patients obtain a medical marijuana card secret from the public. This time, the health department does not want to reveal how often individual physicians approve patients for the medical program —... Read more
LAS VEGAS (Feb. 16, 2022) – Cannabis Conference, the cannabis industry’s leading educational event for plant-touching businesses, has announced its Advisory Board for 2023. Now in its seventh year and produced by award-winning media brand Cannabis Business Times (CBT), Cannabis Conference will return to the Paris Las Vegas Hotel & Casino... Read more
TALLAHASSEE, Fla., Feb. 15, 2023 – PRESS RELEASE – Trulieve Cannabis Corp., a leading and top-performing cannabis company in the United States, claimed Feb. 15 to be the first multistate operator in the cannabis industry to launch advertising campaigns on Twitter. This follows a policy change made by the global social media platform on... Read more
2022 was a terrible year for cannabis stocks. In fact, the 70.4% decline in the New Cannabis Ventures Global Cannabis Stock Index was the worst year ever. It followed a very disappointing year that saw the index decline after peaking at over 4 times the low level from early... Read more
In a letter sent to attorney Rod Kight Feb. 13, the U.S. Drug Enforcement Administration (DEA) declared delta-8- and delta-9-THC-O acetate as Schedule I controlled substances. Kight sent a letter to the DEA Aug. 17, 2022, inquiring about the cannabinoids’ legal status under the Controlled Substances Act (CSA). “I... Read more
It’s been five years since California launched adult-use cannabis sales in 2018, and nearly two-thirds of the state’s cities and counties still prohibit dispensaries within their jurisdictions. To encourage more local governments to host cannabis retailers, the California Department of Cannabis Control (DCC) announced Feb. 14 that it has launched... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )